These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29946601)

  • 21. Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products.
    Rodrigues Felix C; Gupta R; Geden S; Roberts J; Winder P; Pomponi SA; Diaz MC; Reed JK; Wright AE; Rohde KH
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A New Benzothiazolthiazolidine Derivative, 11726172, Is Active
    Salina EG; Postiglione U; Chiarelli LR; Recchia D; Záhorszká M; Lepioshkin A; Monakhova N; Pál A; Porta A; Zanoni G; Korduláková J; Kazakova E; Sassera D; Pasca MR; Makarov V; Degiacomi G
    mSphere; 2022 Dec; 7(6):e0036922. PubMed ID: 36377880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
    Majewski MW; Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2068-71. PubMed ID: 26951749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis.
    Fumagalli F; de Melo SMG; Ribeiro CM; Solcia MC; Pavan FR; da Silva Emery F
    Bioorg Med Chem Lett; 2019 Apr; 29(8):974-977. PubMed ID: 30803803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis.
    Silva PB; Souza PC; Calixto GM; Lopes Ede O; Frem RC; Netto AV; Mauro AE; Pavan FR; Chorilli M
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of human beta defensin-1 and its motif against active and dormant Mycobacterium tuberculosis.
    Sharma R; Saikia UN; Sharma S; Verma I
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7239-7248. PubMed ID: 28856417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel dihydropyrimidines as a potential new class of antitubercular agents.
    Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allylic thiocyanates as a new class of antitubercular agents.
    Silveira GP; Ferreira M; Fernandes L; Moraski GC; Cho S; Hwang C; Franzblau SG; Sá MM
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6486-9. PubMed ID: 22967767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones.
    de Macedo MB; Kimmel R; Urankar D; Gazvoda M; Peixoto A; Cools F; Torfs E; Verschaeve L; Lima ES; Lyčka A; Milićević D; Klásek A; Cos P; Kafka S; Košmrlj J; Cappoen D
    Eur J Med Chem; 2017 Sep; 138():491-500. PubMed ID: 28689097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-Target Antitubercular Drugs.
    de Oliveira Viana J; Ishiki HM; Scotti MT; Scotti L
    Curr Top Med Chem; 2018; 18(9):750-758. PubMed ID: 29807515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives.
    Sajja Y; Vanguru S; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5119-5121. PubMed ID: 29113761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating
    Lopez Quezada L; Li K; McDonald SL; Nguyen Q; Perkowski AJ; Pharr CW; Gold B; Roberts J; McAulay K; Saito K; Somersan Karakaya S; Javidnia PE; Porras de Francisco E; Amieva MM; Dı Az SP; Mendoza Losana A; Zimmerman M; Liang HH; Zhang J; Dartois V; Sans S; Lagrange S; Goullieux L; Roubert C; Nathan C; Aubé J
    ACS Infect Dis; 2019 Aug; 5(8):1433-1445. PubMed ID: 31184461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-Methyl-1H-2-imidazo[4,5-b]pyridinecarboxylic acid and some of its derivatives with suspected antituberculotic activity.
    Bukowski L; Janowiec M
    Pharmazie; 1996 Jan; 51(1):27-30. PubMed ID: 8999430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
    Matyugina E; Novikov M; Babkov D; Ozerov A; Chernousova L; Andreevskaya S; Smirnova T; Karpenko I; Chizhov A; Murthu P; Lutz S; Kochetkov S; Seley-Radtke KL; Khandazhinskaya AL
    Chem Biol Drug Des; 2015 Dec; 86(6):1387-96. PubMed ID: 26061192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the homolytic cleavage of the N,O bond in N-(methoxy)pyridine-2(1H)-thione and N-(methoxy)thiazole-2(3H)-thione in thermally and photochemically induced reactions: a theoretical study.
    Arnone M; Hartung J; Engels B
    J Phys Chem A; 2005 Jul; 109(26):5943-50. PubMed ID: 16833928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
    Gold B; Smith R; Nguyen Q; Roberts J; Ling Y; Lopez Quezada L; Somersan S; Warrier T; Little D; Pingle M; Zhang D; Ballinger E; Zimmerman M; Dartois V; Hanson P; Mitscher LA; Porubsky P; Rogers S; Schoenen FJ; Nathan C; Aubé J
    J Med Chem; 2016 Jul; 59(13):6027-44. PubMed ID: 27144688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
    Singh S; Roy KK; Khan SR; Kashyap VK; Sharma A; Jaiswal S; Sharma SK; Krishnan MY; Chaturvedi V; Lal J; Sinha S; Dasgupta A; Srivastava R; Saxena AK
    Bioorg Med Chem; 2015 Feb; 23(4):742-52. PubMed ID: 25614114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and characterization of Fe(III) and Pb(ll) complexes with 3-hydroxypyridine-2(1H)-thiones.
    Katoh A; Harada K; Saito R
    Hemoglobin; 2006; 30(1):81-92. PubMed ID: 16540420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.